cerebrovascular disease
Conditions
Interventions
Exposure group: Edaravondexcamphorol was used, and the compatibility and timing of administration were not specified according to clinical practice.:N/A
Non-exposed group: Edaravondexcamphenol was not used, and compatibility was not defined according to clinical practice:N/A
Sponsors
Guangxi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 89 Years
Inclusion criteria
Inclusion criteria: 1) Age 18-89 years old. 2) Acute non-disabling ischemic stroke (randomized NIHISS= 4 score) was classified as non-cardiogenic ischemic stroke according to the TOAST score. Informed consent was obtained and participants agreed to participate. 3) The time from the onset of stroke to hospital admission is no more than 7 days.
Exclusion criteria
Exclusion criteria: 1) Pregnant or lactating patients and planned pregnancy within 90 days. 2) Patients with severe renal failure (eGFR < 30ml/min). 3) Patients with serious mental disorders or dementia who cannot cooperate to complete informed consent and follow-up. 4) Patients complicated with malignant tumors or severe systemic diseases with an estimated survival time of less than 90 days.Have participated in, or are currently enrolled in, another clinical intervention study within 30 days of enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mRS Score;90 days of new stroke events; | — |
Secondary
| Measure | Time frame |
|---|---|
| NIHSS scale score;safety; | — |
Countries
China
Contacts
Public ContactWu Yuan
Guangxi Medical University
Outcome results
None listed